AOD-9604

Examine AOD-9604 human obesity results, animal fat-metabolism studies, GH fragment identity, safety reporting and joint-repair claims.

Cagrilintide

Explore cagrilintide biology, monotherapy weight-loss findings, newer diabetes research, tolerability and the distinction from CagriSema combination results.

CJC-1295 DAC

Explore CJC-1295 DAC human research, GH and IGF-1 findings, formulation differences, FDA safety concerns and the limits of claimed physical benefits.

DSIP

Compare small DSIP sleep studies, including favorable early signals and weak insomnia results, with careful attention to timing, function and safety gaps.

HCG

Examine HCG fertility and testosterone research, distinguish hormone measurements from reproductive outcomes, and assess unsupported weight-loss claims.

HGH 191AA

Separate HGH replacement from enhancement claims using original body-composition and athlete trials, official labeling and diagnostic guidance.

IGF-1 LR3

Examine IGF-1 LR3 heart-cell and animal findings, distinguish organ growth from muscle gain, and assess limits of potency and exposure claims.

Ipamorelin

Examine ipamorelin human hormone studies, the postoperative trial, animal findings and FDA safety concerns without overstating clinical benefits.

Gonadorelin

Understand Gonadorelin stimulation research, pulsatile GnRH fertility outcomes, guideline evidence grades and limits of hormone-response claims.

Kisspeptin

Review kisspeptin-10 and kisspeptin-54 human research on hormones, IVF, sexual desire and anxiety, with clear safety and evidence limits.